A prospective randomized trial to study glycemic control, safety and adherence when switching from gliclazide plus metformin to precombined glibenclamide/metformin.
Phase of Trial: Phase IV
Latest Information Update: 29 Jul 2015
At a glance
- Drugs Glibenclamide/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.